PlainRecalls
FDA Drug Low Class III Terminated

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.

Reported: February 14, 2018 Initiated: January 19, 2018 #D-0250-2018

Product Description

Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.

Reason for Recall

Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.

Details

Recalling Firm
G & W Laboratories, Inc.
Units Affected
142,236 tubes
Distribution
Nationwide in the USA and Puerto Rico
Location
South Plainfield, NJ

Frequently Asked Questions

What product was recalled?
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.. Recalled by G & W Laboratories, Inc.. Units affected: 142,236 tubes.
Why was this product recalled?
Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 14, 2018. Severity: Low. Recall number: D-0250-2018.